{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:54:34Z","timestamp":1760608474109},"reference-count":56,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.vaccine.2007.12.035","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T12:36:48Z","timestamp":1200400608000},"page":"1173-1184","source":"Crossref","is-referenced-by-count":36,"title":["Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination"],"prefix":"10.1016","volume":"26","author":[{"given":"Marina \u00c2ngela","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana Maria","family":"El\u00f3i-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Geraldo Leite","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Peruhype-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula Vieira","family":"Marciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erna Geessien","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.12.035_bib1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.1996.03540140045025","article-title":"Yellow fever: a decade of reemergence","volume":"276","author":"Robertson","year":"1996","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2007.12.035_bib2","first-page":"244","article-title":"Yellow fever: reflections on the disease, prospects for the century and risk of re-urbanization","volume":"5","author":"Vasconcelos","year":"2002","journal-title":"Braz J Epidemiol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib3","series-title":"Vaccines","first-page":"741","article-title":"Yellow fever vaccine","author":"Freestone","year":"1994"},{"key":"10.1016\/j.vaccine.2007.12.035_bib4","series-title":"Vaccines","first-page":"815","article-title":"Yellow fever","author":"Monath","year":"1999"},{"key":"10.1016\/j.vaccine.2007.12.035_bib5","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2007.12.035_bib6","unstructured":"World Health Organization. Global programme for vaccines and immunization\/Division of emerging and other communicable diseases surveillance and control. Yellow fever\u2014technical consensus meeting. Geneva; 1998. [Document WHO\/EPI\/GEN\/98.08]."},{"key":"10.1016\/j.vaccine.2007.12.035_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.12.035_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.12.035_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17D vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.12.035_bib10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.12.035_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/viro.2001.1255","article-title":"Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E","volume":"293","author":"Co","year":"2002","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.035_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.2006.03317.x","article-title":"Activation\/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?","volume":"148","author":"Martins","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/nm1159","article-title":"An innately interesting decade of research in immunology","volume":"10","author":"German","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.12.035_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.arcmed.2005.04.007","article-title":"Innate immune responses to Dengue Virus","volume":"36","author":"Navarro-S\u00e1nchez","year":"2005","journal-title":"Arch Med Res"},{"key":"10.1016\/j.vaccine.2007.12.035_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.12.035_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-0-387-34814-8_3","article-title":"Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D","volume":"590","author":"Querec","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virol.2005.09.058","article-title":"Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-\u03b2 TNF-\u03b1 and NK cells activity","volume":"345","author":"Quaresma","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.12.035_bib18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0264-410X(98)00320-X","article-title":"Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine","volume":"17","author":"Stefano","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.035_bib19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4049\/jimmunol.117.3.953","article-title":"Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes","volume":"117","author":"Theofilopoulos","year":"1976","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.68.2.702-707.2000","article-title":"Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation","volume":"68","author":"Juffrie","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.035_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/1074-7613(95)90164-7","article-title":"CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b and CD 18 and CD11c-CD18","volume":"3","author":"Lecoanet-Henchoz","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2007.12.035_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0198-8859(02)00689-4","article-title":"CD28 signaling in neutrophil induces T-cell chemotactic factor(s) modulating T-cell response","volume":"64","author":"Venuprasad","year":"2003","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.12.035_bib23","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/1521-4141(200105)31:5<1536::AID-IMMU1536>3.0.CO;2-8","article-title":"CD28 expression on human neutrophils. I. CD28 regulates neutrophil migration by modulating CXCR-1 expression","volume":"31","author":"Venuprasad","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.190.4.487","article-title":"Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon-\u03b3): inhibition by immunoglobulin A complexes","volume":"190","author":"Woerly","year":"1999","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2007.12.035_bib25","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.4049\/jimmunol.166.8.5201","article-title":"Intracellular pool of IL-10 receptors in specific granules of human neutrophils: differential mobilization by proinflammatory mediators","volume":"166","author":"Elbim","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2567.1997.00440.x","article-title":"Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leukocytes","volume":"90","author":"Bussolati","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2007.12.035_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-3083.1997.d01-393.x","article-title":"Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils","volume":"45","author":"Capsoni","year":"1997","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF02252942","article-title":"Effect in vitro of interferon-\u03b3 and interleukin-10 on generation of oxidizing species by human granulocytes","volume":"45","author":"Chaves","year":"1996","journal-title":"Inflamm Res"},{"key":"10.1016\/j.vaccine.2007.12.035_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1574-695X.1996.tb00084.x","article-title":"Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity","volume":"15","author":"Laichalk","year":"1996","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01315703","article-title":"Replication of virulent and attenuated strains of yellow fever virus in human monocytes and macrophages-like cells (U937)","volume":"76","author":"Liprandi","year":"1983","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.12.035_bib32","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1002\/eji.1830251232","article-title":"CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection","volume":"23","author":"Thieblemont","year":"1995","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.12.035_bib33","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.168.7.3536","article-title":"The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF","volume":"168","author":"Ku","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20011608","article-title":"The CD16+(Fc\u03b3RIII+) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting","volume":"196","author":"Randolph","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.12.035_bib35","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/517806","article-title":"In vivo synthesis of tumor necrosis factor-a in healthy humans after live yellow fever vaccination","volume":"177","author":"Hacker","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.12.035_bib36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/jlb.49.5.511","article-title":"Biology of human immunoglobulin G Fc receptors","volume":"49","author":"Van de Winkel","year":"1991","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.12.035_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1286-4579(00)01360-5","article-title":"Stimulatory and inhibitory signals originating from the macrophage Fc gamma receptors","volume":"3","author":"Gerber","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2007.12.035_bib38","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","article-title":"IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.12.035_bib39","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib40","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.4049\/jimmunol.151.11.6370","article-title":"Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes, comparison with IL-4 and modulation by IFN-gamma or IL-10","volume":"151","author":"de Waal Malefyt","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib41","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4049\/jimmunol.152.3.1354","article-title":"Macrophage-colony-stimulating factor expression by anti-CD45 stimulated human monocytes is transcriptionally up-regulated by IL-1 beta and inhibited by IL-4 and IL-10","volume":"152","author":"Gruber","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib42","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.4049\/jimmunol.155.9.4412","article-title":"Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages","volume":"155","author":"Berkman","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib43","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4049\/jimmunol.158.3.1033","article-title":"Identification through bioinformatics of two new macrophage proinflammatory human chemokines MIP 3-\u03b1 and MIP 3-\u03b2","volume":"158","author":"Rossi","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib44","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.4049\/jimmunol.163.3.1537","article-title":"Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo","volume":"163","author":"Kopydlowski","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib45","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/intimm\/6.4.661","article-title":"IL-10 inhibits prostaglandin E2 production by lipopolysaccharide stimulated monocytes","volume":"6","author":"Niiro","year":"1994","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib46","doi-asserted-by":"crossref","first-page":"21322","DOI":"10.1016\/S0021-9258(17)31965-8","article-title":"Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production","volume":"269","author":"Mertz","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2007.12.035_bib47","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.4049\/jimmunol.164.11.5998","article-title":"Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells","volume":"164","author":"Muzio","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jlb.67.1.97","article-title":"Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and anti-inflammatory stimuli","volume":"67","author":"Buechler","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/cimm.1997.1175","article-title":"Cord blood CD16+CD56\u2212 cells with low activity are possible precursors of mature natural killer cells","volume":"180","author":"Gaddy","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2007.12.035_bib51","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood.V85.12.3577.bloodjournal85123577","article-title":"The functional characterization of interleukin-l0 receptor expression on human natural killer cells","volume":"85","author":"Carson","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2007.12.035_bib52","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1084\/jem.20042530","article-title":"Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection","volume":"202","author":"Glass","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.12.035_bib53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jmv.20205","article-title":"Different chemokine expression in lethal and non-lethal murine West Nile virus infection","volume":"74","author":"Shirato","year":"2004","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.035_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20051970","article-title":"CCR5 deficiency increases risk of symptomatic West Nile virus infection","volume":"203","author":"Glass","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.12.035_bib55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.virol.2005.07.035","article-title":"Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression","volume":"342","author":"Svetlana","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.12.035_bib56","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1086\/425016","article-title":"Activation of the cytokine network and unfavorable outcome in patients with yellow fever","volume":"190","author":"ter Meulen","year":"2004","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07015228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07015228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T21:13:09Z","timestamp":1684185189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07015228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0264410X07015228"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.12.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}